S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

TNXP Tonix Pharmaceuticals Holding Corporation

29.00

-0.77 (-2.59%)

Pre Market

Last Updated: 23:16:42

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Tonix Pharmaceuticals Charts.

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Tonix Pharmaceuticals Charts.

Tonix Pharmaceuticals Holding Corporation News

Form 8-K - Current report
Monday 24 March 2025 (2 days ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
Monday 24 March 2025 (2 days ago) • GlobeNewswire Inc.

Form PRE 14A - Other preliminary proxy statements
Saturday 22 March 2025 (5 days ago) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Wednesday 19 March 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 19 March 2025 (1 week ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 19 March 2025 (1 week ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Wednesday 19 March 2025 (1 week ago) • GlobeNewswire Inc.

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Friday 14 March 2025 (2 weeks ago) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
Thursday 13 March 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 10 March 2025 (2 weeks ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
Monday 10 March 2025 (2 weeks ago) • GlobeNewswire Inc.

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
Wednesday 5 March 2025 (3 weeks ago) • GlobeNewswire Inc.

More Tonix Pharmaceuticals Holding Corporation News Articles

Verizon Communications

Westpac Banking

Australia And New Zealan...

Commonwealth Bank Of Aus...

AUD vs US Dollar

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions